Continuous Glucose Monitoring in Intensive Care Unit

Launched by INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE · Oct 14, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the use of Continuous Glucose Monitoring (CGM) devices in patients who are in the Intensive Care Unit (ICU) to see if they can help keep blood sugar levels within a healthy range. Managing blood sugar in ICU patients can be tough for nurses, and while CGMs are commonly used for people with diabetes outside the hospital, there isn't much information about how well they work in critical care settings. The goal is to find out if these devices are reliable and can improve glucose control for patients recovering from major surgeries.

To be eligible for the trial, participants must be between 18 and 80 years old and undergoing specific surgeries, such as pancreas or liver transplants, or major surgery if they have diabetes. Those who take part will have their blood sugar monitored using the CGM, and the accuracy of the device will be compared to standard blood tests. This study aims to improve the care patients receive in the ICU and help nurses manage blood sugar levels more effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• 1. Male or female patients, of 18 to 80 years of age, undergoing one of the following surgical procedures and post-operative care at ICU:
• • 1. pancreas surgery - total or partial pancreas resection
• • 2. orthotopic liver transplantation
• • 3. simultaneous pancreas and kidney transplantation
• • 4. patients with diabetes mellitus undergoing major surgery
• • 2. Patient must have signed the Patient Informed Consent Form.
• Exclusion Criteria:
• • Any criteria that would disable surgical procedures involved